Patents by Inventor Yi Mi

Yi Mi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline derivative
    Patent number: 10774079
    Abstract: Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: September 15, 2020
    Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
    Inventors: Ying Shi, Qingzhi Gao, Xiaozhuo Chen, Yi Mi, Yaran Zhang, Hanyu Yang, Yujie Chen, Chunlei Liu, Guorui Mi, Yuxiu Ma, Dongmin Shen, Yang Guo, Linjing Fan
  • Method, device and server for recognizing characters of claim document, and storage medium
    Patent number: 10650231
    Abstract: The disclosure discloses a method, device and server of recognizing characters of a claim document, and a storage medium. The method includes: after the server receives a claim document image to be subjected to character recognition, performing region segmentation according to the frame line layout of a claim document frame format, thus obtaining one or multiple segmented regions; and calling a predetermined analysis model to analyze all the obtained segmented regions, and respectively performing character recognition on all the analyzed segmented regions by using a predetermined recognition rule to recognize characters in all the segmented regions.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: May 12, 2020
    Assignee: PING AN TECHNOLOGY (SHENZHEN) CO., LTD.
    Inventors: Feihu Jin, Yan Xue, Yi Mi, Huanhuan Li, Yi Qiu
  • Benzamide derivative
    Patent number: 10550073
    Abstract: The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R1, Z and Q are as described in the description.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: February 4, 2020
    Assignee: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
    Inventors: Ying Shi, Yi Mi, Hanyu Yang, Xuliang Wang, Denghuang Gong, Min Bai, Xiaozhuo Chen, Yujie Chen, Xuejiao Zhang, Yuxiu Ma, Qingzhi Gao
  • QUINAZOLINE DERIVATIVE
    Publication number: 20190367500
    Abstract: Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.
    Type: Application
    Filed: August 8, 2019
    Publication date: December 5, 2019
    Inventors: Ying SHI, Qingzhi GAO, Xiaozhuo CHEN, Yi MI, Yaran ZHANG, Hanyu YANG, Yujie CHEN, Chunlei LIU, Guorui MI, Yuxiu MA, Dongmin SHEN, Yang GUO, Linjing FAN
  • Quinazoline derivative
    Patent number: 10421754
    Abstract: Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: September 24, 2019
    Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
    Inventors: Ying Shi, Qingzhi Gao, Xiaozhuo Chen, Yi Mi, Yaran Zhang, Hanyu Yang, Yujie Chen, Chunlei Liu, Guorui Mi, Yuxiu Ma, Dongmin Shen, Yang Guo, Linjing Fan
  • METHOD, DEVICE AND SERVER FOR RECOGNIZING CHARACTERS OF CLAIM DOCUMENT, AND STORAGE MEDIUM
    Publication number: 20190147239
    Abstract: The disclosure discloses a method, device and server of recognizing characters of a claim document, and a storage medium. The method includes: after the server receives a claim document image to be subjected to character recognition, performing region segmentation according to the frame line layout of a claim document frame format, thus obtaining one or multiple segmented regions; and calling a predetermined analysis model to analyze all the obtained segmented regions, and respectively performing character recognition on all the analyzed segmented regions by using a predetermined recognition rule to recognize characters in all the segmented regions.
    Type: Application
    Filed: June 30, 2017
    Publication date: May 16, 2019
    Applicant: PING AN TECHNOLOGY (SHENZHEN) CO., LTD.
    Inventors: Feihu JIN, Yan XUE, Yi MI, Huanhuan LI, Yi QIU
  • BENZAMIDE DERIVATIVE
    Publication number: 20180312462
    Abstract: The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R1, Z and Q are as described in the description.
    Type: Application
    Filed: September 30, 2016
    Publication date: November 1, 2018
    Inventors: Ying SHI, Yi MI, Hanyu YANG, Xuliang WANG, Denghuang GONG, Min BAI, Xiaozhuo CHEN, Yujie CHEN, Xuejiao ZHANG, Yuxiu MA, Qingzhi GAO
  • Pyrazolo[3,4-c]pyridine derivatives
    Patent number: 9975893
    Abstract: Disclosed are a compound of formula (I), a tautomer, an optical isomer or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the above-mentioned compounds. The above-mentioned compounds have the activity of inhibiting Xa factor positive effect, and can be used for the preparation of a medicament for preventing and/or treating diseases inhibiting Xa factor positive effect in case of low bleeding risk.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: May 22, 2018
    Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
    Inventors: Ying Shi, Qingzhi Gao, Yi Mi, Xuliang Wang
  • PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES
    Publication number: 20170291896
    Abstract: Disclosed are a compound of formula (I), a tautomer, an optical isomer or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the above-mentioned compounds. The above-mentioned compounds have the activity of inhibiting Xa factor positive effect, and can be used for the preparation of a medicament for preventing and/or treating diseases inhibiting Xa factor positive effect in case of low bleeding risk.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 12, 2017
    Inventors: Ying SHI, Qingzhi GAO, Yi MI, Xuliang WANG
  • QUINAZOLINE DERIVATIVE
    Publication number: 20170226099
    Abstract: Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.
    Type: Application
    Filed: August 11, 2015
    Publication date: August 10, 2017
    Inventors: Ying SHI, Qingzhi GAO, Xiaozhuo CHEN, Yi MI, Yaran ZHANG, Hanyu YANG, Yujie CHEN, Chunlei LIU, Guorui MI, Yuxiu MA, Dongmin SHEN, Yang GUO, Linjing FAN
  • Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof
    Patent number: 8796285
    Abstract: The present invention provides new pyrazol-[1,5-a]-pyrimidone derivates and pharmaceutical compositions comprising said compounds and one or more pharmaceutically acceptable carriers or diluents. The uses of the compounds for the manufacture of potassium channel openers, anti-epilepsy medicaments, anti-anxiety medicaments and analgesic medicaments are also provided in the present invention.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: August 5, 2014
    Assignees: Hebei Medical University, Peking University
    Inventors: Hailin Zhang, Jinlong Qi, Diqun Zhang, Kewei Wang, Fan Zhang, Yan Fu, Yi Mi, Wen Xu, Xiaona Du, Yibing Wu, Qingzhong Jia, Shuangge Yang
  • Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof
    Publication number: 20120088775
    Abstract: The present invention provides new pyrazolo-[1,5-a]-pyrimidone derivates and pharmaceutical compositions comprising said compounds and one or more pharmaceutically acceptable carriers or diluents. The uses of the compounds for the manufacture of potassium channel openers, anti-epilepsy medicaments, anti-anxiety medicaments and analgesic medicaments are also provided in the present invention.
    Type: Application
    Filed: June 3, 2010
    Publication date: April 12, 2012
    Applicants: PEKING UNIVERSITY, HEBEI MEDICAL UNIVERSITY
    Inventors: Hailin Zhang, Jinlong Qi, Diqun Zhang, Kewei Wang, Fan Zhang, Yan Fu, Yi Mi, Wen Xu, Xiaona Du, Yibing Wu, Qingzhong Jia, Shuangge Yang